Evaluation of tumor-infiltrating lymphocytes, PD-L1, and PIK3CA mutations and association with prognosis in HER2-positive early stage breast cancer.
Acta oncologica (Stockholm, Sweden)（2023）
摘要
Patients with low sTILs had a significantly poorer survival, despite adequate treatment with adjuvant therapy.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要